PubMed:12861174
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-163 | Sentence | denotes | Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy. |
| TextSentencer_T2 | 164-174 | Sentence | denotes | OBJECTIVE: |
| TextSentencer_T3 | 175-399 | Sentence | denotes | The purpose of this study was to determine the concentrations of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in pregnancies that are complicated with primary antiphospholipid syndrome. |
| TextSentencer_T4 | 400-413 | Sentence | denotes | STUDY DESIGN: |
| TextSentencer_T5 | 414-562 | Sentence | denotes | Longitudinal blood samples were collected from 8 weeks of gestation in 28 women with treated primary antiphospholipid syndrome and 19 control women. |
| TextSentencer_T6 | 563-688 | Sentence | denotes | Serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 were measured by immunoradiometric assay. |
| TextSentencer_T7 | 689-697 | Sentence | denotes | RESULTS: |
| TextSentencer_T8 | 698-906 | Sentence | denotes | Three antiphospholipid syndrome pregnancies miscarried, four pregnancies had intrauterine growth restriction and preeclampsia, six pregnancies had a thrombotic event, and one pregnancy had abruptio placentae. |
| TextSentencer_T9 | 907-1119 | Sentence | denotes | Mean (+/-SD) birth weight in antiphospholipid syndrome group was 2867 +/- 914 g (control, 3492 +/- 527 g; P =.02), and the mean gestation at delivery was 36.5 +/- 5.2 weeks (control, 40.3 +/- 0.7 weeks; P =.002). |
| TextSentencer_T10 | 1120-1416 | Sentence | denotes | Insulin-like growth factor binding protein-1 and insulin-like growth factor-I concentrations increased with gestational age in both groups (2.8% and 2.4% per week), but insulin-like growth factor binding protein-1 was 61% higher in the antiphospholipid syndrome group (95% CI, 16%-122%; P =.004). |
| TextSentencer_T11 | 1417-1548 | Sentence | denotes | Insulin-like growth factor-I was not significantly different (8% higher in antiphospholipid syndrome; 95% CI, -10% to 30%; P =.41). |
| TextSentencer_T12 | 1549-1560 | Sentence | denotes | CONCLUSION: |
| TextSentencer_T13 | 1561-1736 | Sentence | denotes | Serum concentrations of insulin-like growth factor binding protein-1 are abnormal in the antiphospholipid syndrome group and may reflect abnormalities in trophoblast invasion. |
| T1 | 0-163 | Sentence | denotes | Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy. |
| T2 | 164-174 | Sentence | denotes | OBJECTIVE: |
| T3 | 175-399 | Sentence | denotes | The purpose of this study was to determine the concentrations of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in pregnancies that are complicated with primary antiphospholipid syndrome. |
| T4 | 400-413 | Sentence | denotes | STUDY DESIGN: |
| T5 | 414-562 | Sentence | denotes | Longitudinal blood samples were collected from 8 weeks of gestation in 28 women with treated primary antiphospholipid syndrome and 19 control women. |
| T6 | 563-688 | Sentence | denotes | Serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 were measured by immunoradiometric assay. |
| T7 | 689-697 | Sentence | denotes | RESULTS: |
| T8 | 698-906 | Sentence | denotes | Three antiphospholipid syndrome pregnancies miscarried, four pregnancies had intrauterine growth restriction and preeclampsia, six pregnancies had a thrombotic event, and one pregnancy had abruptio placentae. |
| T9 | 907-1119 | Sentence | denotes | Mean (+/-SD) birth weight in antiphospholipid syndrome group was 2867 +/- 914 g (control, 3492 +/- 527 g; P =.02), and the mean gestation at delivery was 36.5 +/- 5.2 weeks (control, 40.3 +/- 0.7 weeks; P =.002). |
| T10 | 1120-1416 | Sentence | denotes | Insulin-like growth factor binding protein-1 and insulin-like growth factor-I concentrations increased with gestational age in both groups (2.8% and 2.4% per week), but insulin-like growth factor binding protein-1 was 61% higher in the antiphospholipid syndrome group (95% CI, 16%-122%; P =.004). |
| T11 | 1417-1548 | Sentence | denotes | Insulin-like growth factor-I was not significantly different (8% higher in antiphospholipid syndrome; 95% CI, -10% to 30%; P =.41). |
| T12 | 1549-1560 | Sentence | denotes | CONCLUSION: |
| T13 | 1561-1736 | Sentence | denotes | Serum concentrations of insulin-like growth factor binding protein-1 are abnormal in the antiphospholipid syndrome group and may reflect abnormalities in trophoblast invasion. |
Preeclampsia
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 811-823 | ORPHA:275555 | denotes | preeclampsia |
Preeclampsia-compare
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 811-823 | ORPHA:275555 | denotes | preeclampsia |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 25-30 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T2 | 240-245 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T3 | 1561-1566 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | Serum |
| PD-UBERON-AE-B_T4 | 427-432 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| PD-UBERON-AE-B_T5 | 896-905 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placentae |
| PD-UBERON-AE-B_T6 | 1715-1726 | http://purl.obolibrary.org/obo/UBERON_0000088 | denotes | trophoblast |
preeclampsia_genes
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-PreeclampsiaGenes-B_T1 | 31-38 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T2 | 64-71 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T3 | 246-253 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T4 | 279-286 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T5 | 569-576 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T6 | 602-609 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T7 | 1120-1127 | HGNC:INS | denotes | Insulin |
| PD-PreeclampsiaGenes-B_T8 | 1169-1176 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T9 | 1289-1296 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T10 | 1417-1424 | HGNC:INS | denotes | Insulin |
| PD-PreeclampsiaGenes-B_T11 | 1585-1592 | HGNC:INS | denotes | insulin |
| PD-PreeclampsiaGenes-B_T12 | 31-57 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T13 | 64-90 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T14 | 246-272 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T15 | 279-305 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T16 | 569-595 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T17 | 602-628 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T18 | 1120-1146 | HGNC:IGF2 | denotes | Insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T19 | 1169-1195 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T20 | 1289-1315 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T21 | 1417-1443 | HGNC:IGF2 | denotes | Insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T22 | 1585-1611 | HGNC:IGF2 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T23 | 31-57 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T24 | 64-90 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T25 | 246-272 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T26 | 279-305 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T27 | 569-595 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T28 | 602-628 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T29 | 1120-1146 | HGNC:IGF1 | denotes | Insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T30 | 1169-1195 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T31 | 1289-1315 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T32 | 1417-1443 | HGNC:IGF1 | denotes | Insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T33 | 1585-1611 | HGNC:IGF1 | denotes | insulin-like growth factor |
| PD-PreeclampsiaGenes-B_T34 | 64-106 | HGNC:IGFBP7 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T35 | 279-321 | HGNC:IGFBP7 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T36 | 602-644 | HGNC:IGFBP7 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T37 | 1120-1162 | HGNC:IGFBP7 | denotes | Insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T38 | 1289-1331 | HGNC:IGFBP7 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T39 | 1585-1627 | HGNC:IGFBP7 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T40 | 64-106 | HGNC:IGFBP3 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T41 | 279-321 | HGNC:IGFBP3 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T42 | 602-644 | HGNC:IGFBP3 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T43 | 1120-1162 | HGNC:IGFBP3 | denotes | Insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T44 | 1289-1331 | HGNC:IGFBP3 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T45 | 1585-1627 | HGNC:IGFBP3 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T46 | 64-106 | HGNC:IGFBP2 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T47 | 279-321 | HGNC:IGFBP2 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T48 | 602-644 | HGNC:IGFBP2 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T49 | 1120-1162 | HGNC:IGFBP2 | denotes | Insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T50 | 1289-1331 | HGNC:IGFBP2 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T51 | 1585-1627 | HGNC:IGFBP2 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T52 | 64-106 | HGNC:IGFBP4 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T53 | 279-321 | HGNC:IGFBP4 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T54 | 602-644 | HGNC:IGFBP4 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T55 | 1120-1162 | HGNC:IGFBP4 | denotes | Insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T56 | 1289-1331 | HGNC:IGFBP4 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T57 | 1585-1627 | HGNC:IGFBP4 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T58 | 64-106 | HGNC:IGFBP5 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T59 | 279-321 | HGNC:IGFBP5 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T60 | 602-644 | HGNC:IGFBP5 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T61 | 1120-1162 | HGNC:IGFBP5 | denotes | Insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T62 | 1289-1331 | HGNC:IGFBP5 | denotes | insulin-like growth factor binding protein |
| PD-PreeclampsiaGenes-B_T63 | 1585-1627 | HGNC:IGFBP5 | denotes | insulin-like growth factor binding protein |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 427-432 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| PD-UBERON-AE-B_T2 | 25-30 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T3 | 240-245 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T4 | 563-568 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | Serum |
| PD-UBERON-AE-B_T5 | 1561-1566 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | Serum |
| PD-UBERON-AE-B_T6 | 896-905 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placentae |
| PD-UBERON-AE-B_T7 | 1715-1726 | http://purl.obolibrary.org/obo/UBERON_0000088 | denotes | trophoblast |